These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

938 related items for PubMed ID: 25840571

  • 1. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V, Odalovic S, Sobic-Saranovic D, Petrovic M, Stojiljkovic M, Petrovic N, Kozarevic N, Grozdic-Milojevic I, Obradovic V.
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [Abstract] [Full Text] [Related]

  • 2. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S, Stojiljkovic M, Sobic-Saranovic D, Pandurevic S, Brajkovic L, Milosevic I, Grozdic-Milojevic I, Artiko V.
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z, Szefer J, Zuchora Z, Romanowicz G, Pietrzak T.
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C, Buecher B, Rousseau C, Kraeber-Bodéré F, Flamant M, des Varannes SB, Frampas E, Galmiche JP, Matysiak-Budnik T.
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [Abstract] [Full Text] [Related]

  • 6. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
    Alongi P, Picchio M, Zattoni F, Spallino M, Gianolli L, Saladini G, Evangelista L.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
    [Abstract] [Full Text] [Related]

  • 7. ¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
    Marcus C, Marashdeh W, Ahn SJ, Taghipour M, Subramaniam RM.
    J Nucl Med; 2015 Jul; 56(7):989-94. PubMed ID: 25952738
    [Abstract] [Full Text] [Related]

  • 8. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR, Choi YJ, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [Abstract] [Full Text] [Related]

  • 10. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
    Caglar M, Yener C, Karabulut E.
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
    Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
    Santhosh S, Mittal BR, Kang M, Kapoor R, Gupta R, Rana S, Bhattacharya A, Bhasin D.
    Abdom Imaging; 2015 Jun; 40(5):1131-7. PubMed ID: 25655637
    [Abstract] [Full Text] [Related]

  • 13. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Jun; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 14. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H, Henderson RW, Conti PS.
    J Comput Assist Tomogr; 2007 Jun; 31(2):223-8. PubMed ID: 17414758
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P, Evangelista L, Caobelli F, Spallino M, Gianolli L, Midiri M, Picchio M.
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [Abstract] [Full Text] [Related]

  • 16. The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.
    Shi D, Cai G, Peng J, Li D, Li X, Xu Y, Cai S.
    BMC Cancer; 2015 Dec 21; 15():991. PubMed ID: 26689966
    [Abstract] [Full Text] [Related]

  • 17. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY, Chen D, Zhang XS, Chen ZF, Hu AB.
    J Dig Dis; 2013 Aug 21; 14(8):433-8. PubMed ID: 23615075
    [Abstract] [Full Text] [Related]

  • 18. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
    Wang GH, Lau EW, Shakher R, Binns DS, Hogg A, Drummond E, Hicks RJ.
    Ai Zheng; 2007 Jun 21; 26(6):638-42. PubMed ID: 17562272
    [Abstract] [Full Text] [Related]

  • 19. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.
    Nucl Med Commun; 2011 Dec 21; 32(12):1162-8. PubMed ID: 21946617
    [Abstract] [Full Text] [Related]

  • 20. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B, Schwenzer NF, Gatidis S, Koenigsrainer I, Koenigsrainer A, Beckert S, Mueller M, Claussen CD, Pfannenberg C.
    Rofo; 2014 Apr 21; 186(4):359-66. PubMed ID: 24683168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.